Related references
Note: Only part of the references are listed.The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Mohammad Reza Zinatizadeh et al.
GENES & DISEASES (2021)
Therapeutic targeting of RAS: New hope for drugging the undruggable
Imran Khan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1
Lu Liang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-XL and MCL-1 leads to rapid induction of intrinsic apoptosis
Sarah Kehr et al.
CANCER LETTERS (2020)
MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
Li Tao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Gaofeng Liang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
miR-34a/c induce caprine endometrial epithelial cell apoptosis by regulating circ-8073/CEP55 via the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR pathways
Xiaorui Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression
Lei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2020)
EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir et al.
TRENDS IN CELL BIOLOGY (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells
Linlin Chang et al.
ACTA PHARMACEUTICA SINICA B (2019)
Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer
Nibedita Pradhan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
RAS mutations in human cancers: Roles in precision medicine
Avaniyapuram Kannan Murugan et al.
SEMINARS IN CANCER BIOLOGY (2019)
Natural products as multidrug resistance modulators in cancer
Amit Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
MicroRNA-34a inhibits epithelial-mesenchymal transition of lens epithelial cells by targeting Notch1
Ruifang Han et al.
EXPERIMENTAL EYE RESEARCH (2019)
MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes
[Anonymous]
CELLS (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
Mohammad Mohajeri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer
Weiping Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The epigenetically-regulated miR-34a targeting c-SRC suppresses RAF/MEK/ERK signaling pathway in K-562 cells
Yang Yang et al.
LEUKEMIA RESEARCH (2017)
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis
Mariola Kurowska-Stolarska et al.
NATURE COMMUNICATIONS (2017)
miR-34a expression in human breast cancer is associated with drug resistance
Zhi-Hua Li et al.
ONCOTARGET (2017)
miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness
Qing Zhang et al.
THERANOSTICS (2017)
Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents
Hui Jia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
MiRNA 34a: a therapeutic target for castration-resistant prostate cancer
Marine J. Chalanqui et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway
Li Li et al.
MEDICAL ONCOLOGY (2016)
Notch signaling: switching an oncogene to a tumor suppressor
Camille Lobry et al.
BLOOD (2014)
Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
Eun Young Park et al.
CANCER RESEARCH (2014)
miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway
Dapeng Chen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Multi-Drug-Resistant Cells Enriched From Chronic Myeloid Leukemia Cells by Doxorubicin Possess Tumor-Initiating-Cell Properties
Hong Xin et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)
MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
Xiu-juan Li et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein
Wei-Juan Chen et al.
Chinese Journal of Cancer (2012)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
Atsuhiko Ichimura et al.
MOLECULAR PHARMACOLOGY (2010)
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Yunqing Li et al.
CANCER RESEARCH (2009)
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Elena Gallardo et al.
CARCINOGENESIS (2009)
Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis
Suruchi Mittal et al.
MOLECULAR CANCER (2009)
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Helen M. Coley
CANCER TREATMENT REVIEWS (2008)
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Cecilia Sahlgren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion
Lu-Gang Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The love-hate relationship between Ras and Notch
MV Sundaram
GENES & DEVELOPMENT (2005)
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappa B
LV Madrid et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
